Buy or sell Akston Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Akston Biosciences Stock

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.

About Akston Biosciences Stock

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. It was founded in 2011 and headquartered in Beverly, Massachusetts.

Funding History

February 2013$700K
May 2015$1.6M
September 2015$250K
August 2016$3.4M
February 2017$998K
February 2018$999K
May 2018$3.9M
June 2019$979K
April 2020$7.8M
May 2020$924K
June 2021$19.9M
April 2022$5.2M

Management

Co-founder, President, and CEO

Todd C. Zion

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo